Latest Announcements
- 14-06-2013 - Positive New Animal Data on ATL1103
- 04-06-2013 - ATL1102 for MS – Dosing Starts in Key Toxicology Study
- 18-04-2013 - Ozequities Newsletter - Feature on ANP
- 09-04-2013 - ATL1103 Phase II trial - dosing of patients commences
- +61 (3) 9827 8999
- Send us a message
- + 61 (3) 9827 1166
Antisense Therapeutics Limited
Level 1, 10 Wallace Avenue
Toorak, Victoria, 3142
Australia
